Dow Down 0.32% Nasdaq Down 0.62%

More On OXB.L

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Oxford BioMedica PLC (OXB.L)

-LSE
5.70 Up 0.18(3.26%) Apr 29, 11:35AM EDT
Prev Close:5.52
Open:5.50
Bid:5.69 x 5000000
Ask:5.71 x 2480000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:5.25 - 5.85
52wk Range:5.00 - 12.03
Volume:563,875
Avg Vol (3m):2,473,130
Market Cap:146.36M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,067.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.58
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback